The Task Force strives to avoid bias by selecting experts from a broad array of backgrounds representing different geographic ACC/AHA TASK FORCE MEMBERS Jonathan L. Halperin, MD, FACC, FAHA, Chair; Glenn N. Levine, MD, FACC, FAHA, Chair-Elect; Jeffrey L. Anderson, MD, FACC, FAHA, Immediate Past Chair**; Nancy M. Albert, PhD, RN, FAHA**; Sana M. Al-Khatib, MD, MHS, FACC, FAHA; Kim K. Birtcher, PharmD, MS, AACC; Biykem Bozkurt, MD, PhD, FACC, FAHA; Ralph G. Brindis, MD, MPH, MACC; Joaquin E. Cigarroa, MD, FACC; Lesley H. Curtis, PhD, FAHA; Lee A. Fleisher, MD, FACC, FAHA; Federico Gentile, MD, FACC; Samuel Gidding, MD, FAHA; Mark A. Hlatky, MD, FACC; John Ikonomidis, MD, PhD, FAHA; Jose Joglar, MD, FACC, FAHA; Richard J. Kovacs, MD, FACC, FAHA**; E. Magnus Ohman, MD, FACC**; Susan J. Pressler, PhD, RN, FAHA; Frank W. Sellke, MD, FACC, FAHA**; Win-Kuang Shen, MD, FACC, FAHA**; Duminda N. Wijeysundera, MD, PhD Levine et al 2015 ACC/AHA/SCAI Focused Update on Primary PCI 1137 regions, sexes, ethnicities, intellectual perspectives/biases, and scopes of clinical practice, and by inviting organizations and professional societies with related interests and expertise to participate as partners or collaborators. Related Issues For additional information pertaining to the methodol- ogy for grading evidence, assessment of benefit and harm, shared decision making between the patient and clinician, structure of evidence tables and summaries, standardized terminology for articulating recommendations, organi- zational involvement, peer review, and policies for peri- odic assessment and updating of guideline documents, we encourage readers to consult the ACC/AHA guideline The recommendations in this focused update represent the official policy of the ACC and AHA until superseded by pub- lished addenda, statements of clarification, focused updates, or revised full-text guidelines. To ensure that guidelines remain current, new data are reviewed biannually to determine whether recommendations should be modified. 